Predictions
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€3.82
09.01.23
09.01.23
-
09.01.24
09.01.24
106.03%
17.01.23
17.01.23
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€7.75
20.09.22
20.09.22
€3.00
20.09.23
20.09.23
-52.24%
11.01.23
11.01.23
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Very low/no dividend yield expected
very negative Cash Flow expected
Novavax Inc.
Start price
Target price
Perf. (%)
€21.36
13.10.22
13.10.22
€20.00
13.10.23
13.10.23
-48.44%
11.01.23
11.01.23
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€1.90
10.01.23
10.01.23
€3.00
10.01.24
10.01.24
52.62%
11.01.23
11.01.23
Could be very worthwhile Investment >20% year
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€13.26
09.01.22
09.01.22
-
09.01.23
09.01.23
7.05%
10.01.23
10.01.23
Risky Investment
Immunogen Inc.
Start price
Target price
Perf. (%)
€4.33
24.12.22
24.12.22
€7.00
31.12.25
31.12.25
-8.10%
09.01.23
09.01.23
Could be very worthwhile Investment >20% year
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€3.68
04.01.23
04.01.23
€5.00
31.12.25
31.12.25
25.54%
09.01.23
09.01.23
Could be very worthwhile Investment >20% year
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.27
03.01.23
03.01.23
-
03.01.24
03.01.24
-5.60%
08.01.23
08.01.23
Could be worthwhile Investment >10% per year
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.33
27.12.22
27.12.22
-
27.12.23
27.12.23
-57.45%
06.01.23
06.01.23
Could be very worthwhile Investment >20% year
Cytomx Therapeutics Inc
Start price
Target price
Perf. (%)
€1.73
05.01.23
05.01.23
€3.00
31.12.25
31.12.25
37.80%
06.01.23
06.01.23
Could be very worthwhile Investment >20% year
Geron Corp.
Start price
Target price
Perf. (%)
€2.50
04.01.23
04.01.23
€6.00
31.12.25
31.12.25
38.38%
04.01.23
04.01.23
Could be very worthwhile Investment >20% year
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€13.70
30.09.22
30.09.22
€9.00
31.01.23
31.01.23
-12.08%
03.01.23
03.01.23
Could be very worthwhile Investment >20% year
Meta Material Inc.
Start price
Target price
Perf. (%)
€1.03
26.12.22
26.12.22
-
03.03.23
03.03.23
9.95%
02.01.23
02.01.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€32.60
28.12.22
28.12.22
€40.00
28.12.23
28.12.23
50.15%
02.01.23
02.01.23
Onto Innovation Inc.
Start price
Target price
Perf. (%)
€89.00
30.12.21
30.12.21
€96.00
30.12.22
30.12.22
-28.09%
30.12.22
30.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Future proof or reliable business model
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.32
21.12.22
21.12.22
€11.00
31.03.24
31.03.24
29.21%
28.12.22
28.12.22
Could be very worthwhile Investment >20% year
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.97
27.12.21
27.12.21
€6.00
27.12.22
27.12.22
-83.85%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€4.77
12.12.22
12.12.22
-
12.12.23
12.12.23
-33.89%
27.12.22
27.12.22
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Microstrateg.a New
Start price
Target price
Perf. (%)
€184.72
12.12.22
12.12.22
€380.00
12.12.23
12.12.23
-24.00%
26.12.22
26.12.22
Could be very worthwhile Investment >20% year
Powell Industries Inc.
Start price
Target price
Perf. (%)
€33.80
11.12.22
11.12.22
€37.00
11.12.23
11.12.23
-1.18%
22.12.22
22.12.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
High dividend yield expected
ADTRAN Holdings Inc.
Start price
Target price
Perf. (%)
€19.95
21.11.22
21.11.22
-
21.12.22
21.12.22
-10.53%
22.12.22
22.12.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
ADTRAN Holdings Inc.
Start price
Target price
Perf. (%)
€19.95
21.11.22
21.11.22
-
21.12.22
21.12.22
-10.53%
22.12.22
22.12.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€20.67
26.10.22
26.10.22
€35.00
31.12.24
31.12.24
-41.33%
21.12.22
21.12.22
Could be very worthwhile Investment >20% year
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€5.98
28.11.22
28.11.22
-
28.11.23
28.11.23
-20.32%
12.12.22
12.12.22
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€5.98
28.11.22
28.11.22
-
28.11.23
28.11.23
-20.32%
10.12.22
10.12.22
Risky Investment